Abstract
Objectives
Microwave ablation (MWA) has achieved excellent long-term efficacy in treating unifocal papillary thyroid microcarcinoma (UPTMC). The therapeutic effect of this treatment on multifocal papillary thyroid microcarcinoma (MPTMC) is unknown. Therefore, we evaluated the long-term efficacy of MWA for low-risk MPTMC and to provide evidence-based medicine for the revision of clinical guidelines.
Methods
This study included 66 MPTMC patients with a total of 158 lesions, all of whom received MWA. We collected and retrospectively analyzed the patients’ follow-up data before MWA, at 1, 3, 6, and 12 months posttreatment and every 6 months thereafter until 5 years posttreatment. We evaluated the MWA complication rate, technical success rate (TSR), lesion volume reduction rate (VRR), and complete disappearance rate (CDR) during follow-up and in those patients with tumor progression and delayed surgery.
Results
After 60 months of follow-up, all 158 lesions disappeared in 66 patients, and the volume was reduced from 43.82 mm3 to 0.00 mm3. The TSR and VRR were both 100%. The CDRs at 1 year, 2 years, and 3 years were 57.59%, 93.67%, and 100%, respectively. The complication rate was 3.03% (2/66), and the incidence of tumor progression was 3.03% (2/66), including one new intrathyroidal lesion and one cervical lymph node metastasis (LNM). These lesions were retreated with MWA, and the lesions disappeared during the follow-up period.
Conclusions
Ultrasound-guided MWA for low-risk MPTMC is safe and effective and may serve as an alternative option for patients who refuse surgery or active surveillance (AS).
Clinical relevance statement
This study concludes that ultrasound-guided microwave ablation for low-risk multifocal papillary thyroid microcarcinoma is safe and effective and may serve as an alternative option for patients who refuse surgery or active surveillance.
Key Points
• Ultrasound-guided microwave ablation for low-risk multifocal papillary thyroid microcarcinoma is safe and effective.
• During 5 years of follow-up, multifocal papillary thyroid microcarcinoma patients treated with microwave ablation had a favorable prognosis.
• To provide evidence-based medicine for the revision of clinical guidelines.
Similar content being viewed by others
Abbreviations
- AS:
-
Active surveillance
- ATA:
-
American Thyroid Association
- CDFI:
-
Color Doppler flow imaging
- CDR:
-
Complete disappearance rate
- CEUS:
-
Contrast-enhanced ultrasonography
- CNB:
-
Core needle biopsy
- ETE:
-
Extrathyroidal extension
- FNA:
-
Fine-needle aspiration
- IQR:
-
Interquartile range
- LNM:
-
Lymph node metastasis
- MWA:
-
Microwave ablation
- MPTMC:
-
Multifocal papillary thyroid microcarcinoma
- PTMC:
-
Papillary thyroid microcarcinoma
- TSR:
-
Technical success rate
- TSH:
-
Thyrotropin
- UPTMC:
-
Unifocal papillary thyroid microcarcinoma
- V:
-
Volume
- VRR:
-
Volume reduction rate
References
Miyauchi A, Ito Y, Oda H (2018) Insights into the management of papillary microcarcinoma of the thyroid. Thyroid 28:23–31
Hay ID (2007) Management of patients with low-risk papillary thyroid carcinoma. Endocrine Practice 13:521–533
Jeon YW, Gwak HG, Lim ST, Schneider J, Suh YJ (2019) Long-term prognosis of unilateral and multifocal papillary thyroid microcarcinoma after unilateral lobectomy versus total thyroidectomy. Ann Surg Oncol 26:2952–2958
Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133
Lin X, Finkelstein SD, Zhu B, Silverman JF (2008) Molecular analysis of multifocal papillary thyroid carcinoma. J Mol Endocrinol 41:195–203
Kuhn E, Teller L, Piana S, Rosai J, Merino MJ (2012) Different clonal origin of bilateral papillary thyroid carcinoma, with a review of the literature. Endocr Pathol 23:101–107
Sugitani I, Ito Y, Takeuchi D et al (2021) Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma. Thyroid 31:183–192
Oda H, Miyauchi A, Ito Y et al (2016) Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid 26:150–155
Zanocco KA, Hershman JM, Leung AM (2019) Active surveillance of low-risk thyroid cancer. JAMA 321:2020–2021
Yan L, Zhang M, Song Q, Luo Y (2021) Ultrasound-guided radiofrequency ablation versus thyroid lobectomy for low-risk papillary thyroid microcarcinoma: a propensity-matched cohort study of 884 patients. Thyroid 31:1662–1672
Cao X-J, Wang S-R, Che Y et al (2021) Efficacy and safety of thermal ablation for treatment of solitary T1N0M0 papillary thyroid carcinoma: a multicenter retrospective study. Radiology 300:209–216
Orloff LA, Noel JE, Stack BC Jr et al (2022) Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: an international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association. Head Neck 44:633–660
Cho SJ, Baek SM, Lim HK, Lee KD, Son JM, Baek JH (2020) Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors. Thyroid 30:1745–1751
Baek JH, Cho SJ (2021) Thermal ablation for small papillary thyroid cancer: a potential game changer. Radiology 300:217–218
Kim HJ, Chung SM, Kim H et al (2021) Long-term efficacy of ultrasound-guided laser ablation for papillary thyroid microcarcinoma: results of a 10-year retrospective study. Thyroid 31:1723–1729
Teng DK, Li WH, Du JR, Wang H, Yang DY, Wu XL (2020) Effects of microwave ablation on papillary thyroid microcarcinoma: a five-year follow-up report. Thyroid 30:1752–1758
Yan T, Qiu W, Song J, Ying T, Fan Y, Yang Z (2021) Bilateral multifocality, a marker for aggressive disease, is not an independent prognostic factor for papillary thyroid microcarcinoma: a propensity score matching analysis. Clin Endocrinol (Oxf) 95:209–216
Harries V, Wang LY, McGill M et al (2020) Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma? Surgery 167:10–17
Nagaoka R, Ebina A, Toda K et al (2021) Multifocality and progression of papillary thyroid microcarcinoma during active surveillance. World J Surg 45:2769–2776
Iacobone M, Jansson S, Barczynski M, Goretzki P (2014) Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg 399:141–154
Cho SJ, Baek SM, Na DG, Lee KD, Shong YK and Baek JH, (2021) Five-year follow-up results of thermal ablation for low-risk papillary thyroid microcarcinomas: systematic review and metaanalysis. Eur Radiol 31:6446–6456. https://doi.org/10.1007/s00330-021-07808-x
Teng DK, Li HQ, Sui GQ et al (2019) Preliminary report of microwave ablation for the primary papillary thyroid microcarcinoma: a large-cohort of 185 patients feasibility study. Endocrine 64:109–117
Teng D, Sui G, Liu C, Wang Y, Xia Y, Wang H (2018) Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study. J Cancer Res Clin Oncol 144:771–779
Yan L, Zhang M, Song Q, Xie F, Luo Y (2022) Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study. Eur Radiol 32:1216–1226
Wang F, Yu X, Shen X et al (2017) The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer. J Clin Endocrinol Metab 102:3241–3250
Xue S, Zhang L, Wang P et al (2019) Predictive factors of recurrence for multifocal papillary thyroid microcarcinoma with Braf(v600e) mutation: a single center study of 1,207 Chinese patients. Front Endocrinol (Lausanne) 10:407
Geron Y, Benbassat C, Shteinshneider M et al (2019) Multifocality is not an independent prognostic factor in papillary thyroid cancer: a propensity score-matching analysis. Thyroid 29:513–522
Cho SJ, Suh CH, Baek JH et al (2019) Active surveillance for small papillary thyroid cancer: a systematic review and meta-analysis. Thyroid 29:1399–1408
Slijepcevic N, Zivaljevic V, Diklic A, Jovanovic M, Oluic B, Paunovic I (2018) Risk factors associated with intrathyroid extension of thyroid microcarcinomas. Langenbecks Arch Surg 403:615–622
Jeon MJ, Chung MS, Kwon H et al (2017) Features of papillary thyroid microcarcinoma associated with lateral cervical lymph node metastasis. Clin Endocrinol (Oxf) 86:845–851
Acknowledgements
This study was supported by Finance Department of Jilin Province (NO.2021SCZ26) and Finance Department of Jilin Province (NO.2020SCZ08).
Funding
This study was funded by Finance Department of Jilin Province (NO. 2021SCZ26) and Finance Department of Jilin Province (NO.2020SCZ08).
Author information
Authors and Affiliations
Contributions
Peng Dong: literature research, experimental studies/data analysis, statistical analysis and writing original draft
Deng-Ke Teng: study concepts, review and editing
Guo-Qing Sui: clinical studies and literature research
Yuan-Qiang Lin: statistical analysis
Qiang Luo: literature research and statistical analysis
Qi-Meihui Wang: software and article preparation
He-Qun Li: writing review and editing
Hui Wang: guarantor of integrity of the entire study, review and editing, design
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Hui Wang.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was obtained from all patients in this study.
Ethical approval
This study was approved by the ethics committee of China-Japan Union Hospital of Jilin University.
Study subjects or cohorts overlap
There is no overlap in study subjects or cohorts.
Methodology
-
Retrospective study
-
Diagnostic or prognostic study
-
performed at one institution
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Dong, P., Teng, DK., Sui, GQ. et al. Long-term efficacy of microwave ablation for multifocal papillary thyroid microcarcinoma: a 5-year follow-up study. Eur Radiol 34, 715–723 (2024). https://doi.org/10.1007/s00330-023-10117-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-023-10117-0